Department of Oral and Maxillofacial Surgery, Dental Research Institute, School of Dentistry, Seoul National University, Seoul, Korea; Department of Oral and Maxillofacial Surgery, Seoul National University Dental Hospital, Seoul, Korea.
Department of Oral and Maxillofacial Surgery, Dental Research Institute, School of Dentistry, Seoul National University, Seoul, Korea; Department of Oral and Maxillofacial Surgery, Seoul National University Dental Hospital, Seoul, Korea.
J Stomatol Oral Maxillofac Surg. 2024 Feb;125(1):101648. doi: 10.1016/j.jormas.2023.101648. Epub 2023 Sep 27.
This study investigates the effectiveness of a new double-layer approach for closing oroantral and oronasal fistulas (OA/ONFs) using Matriderm® and Neoveil®. Matriderm®, an acellular dermal matrix composed of collagen and elastin fibers, supports tissue regeneration, while Neoveil®, a biodegradable mesh sheet, serves as a barrier to prevent leakage and scarring.
A retrospective study of 12 maxillectomy patients with oral cancer between January 2022 and May 2023 was conducted. Patient data, including tumor stage, bone invasion, and defect size, were analyzed. Surgical techniques included sinus mucosa preservation, and either buccal fat grafting combined with the double layer technique or the double layer technique alone, with statistical analysis performed using R software to evaluate outcomes.
The results indicate a 41.7% incidence rate of fistula formation with lower T stages, absence of bone invasion, smaller defect dimensions, and intact sinus mucosa correlating with reduced fistula risk (p < 0.05). Notably, no patients required fistula-related surgical revisions, validating the efficacy of the approach.
This study introduced a novel double-layer technique using Matriderm® and Neoveil® for closing OA/ONFs after maxillectomy. The technique demonstrated promising outcomes in addressing these post-operative complications. Lower tumor stages, no bone invasion, smaller defects, and intact sinus mucosa correlated with reduced fistula risk. This technique holds potential to enhance maxillectomy outcomes, offering a comprehensive approach to functional concerns, but warrants further investigation.
本研究旨在探讨使用 Matriderm® 和 Neoveil® 双层方法关闭口腔-上颌窦瘘(OA/ONF)的有效性。Matriderm® 是一种由胶原蛋白和弹性纤维组成的无细胞真皮基质,支持组织再生,而 Neoveil® 是一种可生物降解的网片,用作防止泄漏和瘢痕形成的屏障。
对 2022 年 1 月至 2023 年 5 月期间的 12 例口腔癌上颌骨切除术患者进行了回顾性研究。分析了患者的肿瘤分期、骨侵犯和缺损大小等数据。手术技术包括保留窦黏膜,并采用颊脂垫移植联合双层技术或仅采用双层技术,使用 R 软件进行统计分析评估结果。
结果表明,T 分期较低、无骨侵犯、缺损尺寸较小且窦黏膜完整的患者,瘘管形成的发生率为 41.7%,与瘘管风险降低相关(p<0.05)。值得注意的是,没有患者需要进行瘘管相关的手术修复,验证了该方法的疗效。
本研究介绍了一种使用 Matriderm® 和 Neoveil® 的新型双层技术,用于关闭上颌骨切除术后的 OA/ONF。该技术在解决这些术后并发症方面表现出良好的效果。较低的肿瘤分期、无骨侵犯、较小的缺损和完整的窦黏膜与瘘管风险降低相关。该技术有可能提高上颌骨切除术的效果,为功能问题提供全面的解决方案,但需要进一步研究。